BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krzyzowska M, Chodkowski M, Janicka M, Dmowska D, Tomaszewska E, Ranoszek-Soliwoda K, Bednarczyk K, Celichowski G, Grobelny J. Lactoferrin-Functionalized Noble Metal Nanoparticles as New Antivirals for HSV-2 Infection. Microorganisms 2022;10:110. [PMID: 35056558 DOI: 10.3390/microorganisms10010110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Guzmán-mejía F, Godínez-victoria M, Molotla-torres DE, Drago-serrano ME. Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus. Pharmaceuticals 2023;16:214. [DOI: 10.3390/ph16020214] [Reference Citation Analysis]
2 Sharma D, Sharma S, Akojwar N, Dondulkar A, Yenorkar N, Pandita D, Prasad SK, Dhobi M. An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections. Vaccines 2023;11:206. [DOI: 10.3390/vaccines11020206] [Reference Citation Analysis]
3 Janicka M, Ranoszek-soliwoda K, Chodaczek G, Antos-bielska M, Brytan M, Tomaszewska E, Celichowski G, Grobelny J, Cymerys J, Krzyżowska M, Chodkowski M. Functionalized Noble Metal Nanoparticles for the Treatment of Herpesvirus Infection. Microorganisms 2022;10:2161. [DOI: 10.3390/microorganisms10112161] [Reference Citation Analysis]
4 Smith JB, Herbert JJ, Truong NR, Cunningham AL. Cytokines and chemokines: The vital role they play in herpes simplex virus mucosal immunology. Front Immunol 2022;13:936235. [DOI: 10.3389/fimmu.2022.936235] [Reference Citation Analysis]
5 Krzyzowska M, Janicka M, Tomaszewska E, Ranoszek-Soliwoda K, Celichowski G, Grobelny J, Szymanski P. Lactoferrin-Conjugated Nanoparticles as New Antivirals. Pharmaceutics 2022;14:1862. [PMID: 36145610 DOI: 10.3390/pharmaceutics14091862] [Reference Citation Analysis]